Cargando…

Role of COVID-19 Vaccines in SARS-CoV-2 Variants

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is a threat to the health of the global population. As the result of a global effort in the determination of origin, structure, and pathogenesis of SARS-CoV-2 and its variants, particularly s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Zhou, Zhu, Yimiao, Chu, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165056/ https://www.ncbi.nlm.nih.gov/pubmed/35669787 http://dx.doi.org/10.3389/fimmu.2022.898192

Ejemplares similares

Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan
por: Chao, Chiao-Hsuan, et al.
Publicado: (2022)

Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants
por: Hu, Ye-Fan, et al.
Publicado: (2022)

SARS-CoV-2 Variants, Vaccines, and Host Immunity
por: Mistry, Priyal, et al.
Publicado: (2022)

Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines
por: Zhang, Yandi, et al.
Publicado: (2021)

Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort
por: Zhang, Shihan, et al.
Publicado: (2022)

Neutralization effect of plasma from vaccinated COVID-19 convalescents on SARS-CoV-2 Omicron variants
por: Xie, Yudi, et al.
Publicado: (2022)

Omicron variants of SARS-CoV-2 and long COVID
por: Yang, Chengliang, et al.
Publicado: (2022)

Neutralization of SARS-CoV-2 Variants by mRNA and Adenoviral Vector Vaccine-Elicited Antibodies
por: Tada, Takuya, et al.
Publicado: (2022)

Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infections
por: Qassim, Suelen H., et al.
Publicado: (2022)

SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
por: Pather, Shanti, et al.
Publicado: (2023)

COVID-19 vaccine induced poor neutralization titers for SARS-CoV-2 omicron variants in maternal and cord blood
por: Govindaraj, Sakthivel, et al.
Publicado: (2023)

Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines
por: Flanagan, Katie L., et al.
Publicado: (2020)

Corrigendum: SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
por: Pather, Shanti, et al.
Publicado: (2023)

MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters
por: Boudewijns, Robbert, et al.
Publicado: (2022)

SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
por: Martínez-Flores, Daniel, et al.
Publicado: (2021)

Defining the pediatric response to SARS-CoV-2 variants
por: Ho, Reanne M., et al.
Publicado: (2023)

Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine
por: Melo-González, Felipe, et al.
Publicado: (2021)

Implication of SARS-CoV-2 Immune Escape Spike Variants on Secondary and Vaccine Breakthrough Infections
por: Ahmad, Liyana
Publicado: (2021)

At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron Variant
por: Singanallur, Nagendrakumar B., et al.
Publicado: (2022)

Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies
por: Aparicio, Belén, et al.
Publicado: (2023)

SARS-CoV-2 bivalent mRNA vaccine with broad protection against variants of concern
por: Ma, Qinhai, et al.
Publicado: (2023)

Design of a Recombinant Multivalent Epitope Vaccine Based on SARS-CoV-2 and Its Variants in Immunoinformatics Approaches
por: Yu, Mingkai, et al.
Publicado: (2022)

Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets
por: Oliveira, Sergio C., et al.
Publicado: (2020)

Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern
por: Rudi, Erika, et al.
Publicado: (2022)

Reduced maternal immunity and vertical transfer of immunity against SARS-CoV-2 variants of concern with COVID-19 exposure or initial vaccination in pregnancy
por: Boelig, Rupsa C., et al.
Publicado: (2023)

The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom
por: Wu, Jiajing, et al.
Publicado: (2021)

SARS-CoV-2’s Variants of Concern: A Brief Characterization
por: Scovino, Aline Miranda, et al.
Publicado: (2022)

Editorial: SARS-CoV-2 variants, B lymphocytes, and autoreactivity
por: Radic, Marko Z., et al.
Publicado: (2023)

The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape
por: Tian, Dandan, et al.
Publicado: (2021)

Adherence to Sars-CoV2 vaccination in hematological patients
por: Narinx, Justine, et al.
Publicado: (2022)

Erratum: Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies
por: Aparicio, Belén, et al.
Publicado: (2023)

Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responses
por: Buscot, Matthieu, et al.
Publicado: (2023)

Characterization of RBD-specific cross-neutralizing antibodies responses against SARS-CoV-2 variants from COVID-19 convalescents
por: Wang, Zheng, et al.
Publicado: (2023)

Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination
por: Paniskaki, Krystallenia, et al.
Publicado: (2022)

Decreased severity of COVID‐19 in vaccinated pregnant individuals during predominance of different SARS‐CoV‐2 variants
por: Eid, Joe, et al.
Publicado: (2022)

Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19
por: Zhou, Hong, et al.
Publicado: (2022)

Age-adjusted impact of prior COVID-19 on SARS-CoV-2 mRNA vaccine response
por: Nakagama, Sachie, et al.
Publicado: (2023)

Immunogenicity and efficacy of a novel multi-patch SARS-CoV-2/COVID-19 vaccine candidate
por: Perdiguero, Beatriz, et al.
Publicado: (2023)

Display of receptor-binding domain of SARS-CoV-2 Spike protein variants on the Saccharomyces cerevisiae cell surface
por: Xing, Hongguan, et al.
Publicado: (2022)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
por: Zhang, Yun-yu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qatabng2r7te7v2b2jnb32a7np